Journal of Cachexia Sarcopenia and Muscle

The Journal of Cachexia, Sarcopenia and Muscle (J Cachexia Sarcopeni, ISSN: 2190-5991) is a leading peer-reviewed, open access journal published by Wiley on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. With a 2026 Impact Factor of 9.900 and consistently ranked in the JCR Q1, it stands as a premier venue for translational and clinical research in the fields of muscle wasting and metabolic disorders. The journal’s scope encompasses the full spectrum of cachexia and sarcopenia, including their pathophysiology, epidemiology, diagnosis, and therapeutic interventions. It covers conditions such as cancer cachexia, cardiac cachexia, age-related sarcopenia, and muscle loss in chronic diseases like COPD, kidney failure, and HIV. The journal publishes original research articles, comprehensive reviews, editorials, and short reports, with a strong emphasis on high-quality clinical trials, biomarker studies, and mechanistic investigations. Its target audience includes clinical researchers, geriatricians, oncologists, cardiologists, nutritionists, and basic scientists focused on muscle biology and wasting syndromes. Notable features include full open access, ensuring broad dissemination of findings, and a rigorous editorial process that prioritizes methodological soundness and clinical relevance. The journal’s exceptionally high impact factor and Q1 standing underscore its influence and authority in the field, making it an essential resource for advancing knowledge and treatment strategies for muscle wasting disorders.